Skip to content

Clinical trials

Observational Glycogen Storage Disease Type II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glycogen Storage Disease Type II Phase: Observational Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20075
20082
20091
20101
20112
20122
20133
20144
20156
20165
20172
20183
20193
20201
20217
20224
20233
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status17
Recruiting11
Active, not recruiting5
Withdrawn2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University7
Genzyme, a Sanofi Company7
National Taiwan University Hospital5
LMU Klinikum4
O & O Alpan LLC3
Sanofi3
University of Florida3
Amicus Therapeutics2
CENTOGENE GmbH Rostock2
Centre Hospitalier de Cayenne2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glycogen Storage Disease Type II62
Gaucher Disease5
Glycogen Storage Disease5
Lysosomal Storage Diseases4
Muscular Diseases4
Anemia, Sickle Cell3
Cystic Fibrosis3
Fabry Disease3
Glycogen Storage Disease Type V3
Mucopolysaccharidosis I3

Trials

Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.